ProLactinoma
Microprolactinomasappear as ahypodenseareaon maanetic resonance imaqind. Serum prolactinleveLs
usuallycorrespondtotumoursize.otenabove3000muuin patientswthmacroadenomas.
Management
First-linetherap
dopamineaqoniststouower prouactineveis.decreasetumour sizeand restoregonadat
functionfor patientsharbouring symptomatic prolactin-secreting micro:
macroadenomas.Cabergolineis
used in preferencetootherdopamineaaonistsbecausethas igher efficacy innormalisingprolactinevels,as
wetuasahiaherfreauency of pituitarytumour shrinkaqe.For svmptomatic patientswhodonot achievenormat
prolactinevelsor show sianificantrecucton intumour szeonstandard doses ofadopamineaqonist(resistant
prolactinomas).thedoseshoudbeincreasedtomaximattoerabledoses beforereferrinathepatientfor
surqery.Transsphenoidalsuraeryisreserved for svmptomaticpatients wth prolactinomas whocannottolerate
hiah dosesofcaberqolineor arenotresponsivetodopamineagonisttherapy.
@1MIN ENDOCRINE
